title: Lymphangiosarcoma with strong positivity of D2-40 and LYVE-1 presenting different clinical features from angiosarcoma.
authors.affiliation: Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: Hiroo
authors.initials: H
authors.lastname: Hata
authors.forename: Satoru
authors.initials: S
authors.lastname: Aoyagi
authors.forename: Erina
authors.initials: E
authors.lastname: Homma
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Muramatsu
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived; D003937:Diagnosis, Differential; D005153:Facial Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D006394:Hemangiosarcoma / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008204:Lymphangiosarcoma / Q000175:diagnosis* / Q000378:metabolism; D012535:Scalp; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D033921:Vesicular Transport Proteins / Q000378:metabolism
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C119248:LYVE1 protein, human; D033921:Vesicular Transport Proteins; C500987:monoclonal antibody D2-40